These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 29512413

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Timing of MOG-IgG Testing Is Key to 2023 MOGAD Diagnostic Criteria.
    Forcadela M, Rocchi C, San Martin D, Gibbons EL, Wells D, Woodhall MR, Waters PJ, Huda S, Hamid S.
    Neurol Neuroimmunol Neuroinflamm; 2024 Jan; 11(1):. PubMed ID: 37977848
    [Abstract] [Full Text] [Related]

  • 26. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
    Jarius S, Ruprecht K, Kleiter I, Borisow N, Asgari N, Pitarokoili K, Pache F, Stich O, Beume LA, Hümmert MW, Ringelstein M, Trebst C, Winkelmann A, Schwarz A, Buttmann M, Zimmermann H, Kuchling J, Franciotta D, Capobianco M, Siebert E, Lukas C, Korporal-Kuhnke M, Haas J, Fechner K, Brandt AU, Schanda K, Aktas O, Paul F, Reindl M, Wildemann B, in cooperation with the Neuromyelitis Optica Study Group (NEMOS).
    J Neuroinflammation; 2016 Sep 27; 13(1):280. PubMed ID: 27793206
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Corpus callosum involvement in MOG antibody-associated disease in comparison to AQP4-IgG-seropositive neuromyelitis optica spectrum disorder and multiple sclerosis.
    Chia NH, Redenbaugh V, Chen JJ, Pittock SJ, Flanagan EP.
    Mult Scler; 2023 May 27; 29(6):748-752. PubMed ID: 36691800
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
    Matthews L, Marasco R, Jenkinson M, Küker W, Luppe S, Leite MI, Giorgio A, De Stefano N, Robertson N, Johansen-Berg H, Evangelou N, Palace J.
    Neurology; 2013 Apr 02; 80(14):1330-7. PubMed ID: 23486868
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Brain structural alterations in MOG antibody diseases: a comparative study with AQP4 seropositive NMOSD and MS.
    Duan Y, Zhuo Z, Li H, Tian DC, Li Y, Yang L, Gao C, Zhang T, Zhang X, Shi FD, Barkhof F, Liu Y.
    J Neurol Neurosurg Psychiatry; 2021 Jul 02; 92(7):709-716. PubMed ID: 33687975
    [Abstract] [Full Text] [Related]

  • 33. Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome.
    Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K, BIOMARKER Study Group.
    Neurology; 2017 Aug 29; 89(9):900-908. PubMed ID: 28768844
    [Abstract] [Full Text] [Related]

  • 34. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
    Fan S, Xu Y, Ren H, Guan H, Feng F, Gao X, Ding D, Fang F, Shan G, Guan T, Zhang Y, Dai Y, Yao M, Peng B, Zhu Y, Cui L.
    Mult Scler Relat Disord; 2018 Feb 29; 20():144-152. PubMed ID: 29414288
    [Abstract] [Full Text] [Related]

  • 35. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY, Min JH, Kim W, Kim SH, Kim HJ, Kim BJ, Kim BJ, Lee KH.
    Mult Scler; 2014 May 29; 20(6):695-704. PubMed ID: 24072726
    [Abstract] [Full Text] [Related]

  • 36. A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody-associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis.
    Luo W, Zhong X, Shen S, Fang L, Huang Y, Wang Y, Qiu W.
    Eur J Neurol; 2024 Sep 29; 31(9):e16377. PubMed ID: 38863307
    [Abstract] [Full Text] [Related]

  • 37. Clinical and neuroimaging characteristics of MOG autoimmunity in children with acquired demyelinating syndromes.
    Ferilli MAN, Valeriani M, Papi C, Papetti L, Ruscitto C, Figà Talamanca L, Ursitti F, Moavero R, Vigevano F, Iorio R.
    Mult Scler Relat Disord; 2021 May 29; 50():102837. PubMed ID: 33636614
    [Abstract] [Full Text] [Related]

  • 38. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis.
    Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J.
    Mult Scler; 2022 Feb 29; 28(2):217-227. PubMed ID: 34048323
    [Abstract] [Full Text] [Related]

  • 39. Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.
    Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD.
    Sci China Life Sci; 2016 Dec 29; 59(12):1270-1281. PubMed ID: 26920678
    [Abstract] [Full Text] [Related]

  • 40. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
    Ikeda A, Watanabe Y, Kaba H, Kaneko K, Takahashi T, Takeshita S.
    Brain Dev; 2019 Apr 29; 41(4):367-372. PubMed ID: 30447856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.